NCT06008483 2023-08-23
A Dose Finding Study to Treat Bone Tumor(s)
QSAM Therapeutics, Inc.
Phase 1 Unknown
Clinical Trials
4 trialsNCT04178044 2019-11-26
Phase â… Clinical Study Protocol of GB223 Monoclonal Antibody Injection
Genor Biopharma Co., Ltd.
Phase 1 Unknown
NCT03527888 2019-05-21
Study of Anlotinib in Patients With Primary Malignant Bone Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT02293031 2017-03-07
Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery
NextGen Company Limited
Phase NA Unknown